Dolby Laboratories’ (DLB) Buy Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities restated their buy rating on shares of Dolby Laboratories (NYSE:DLBFree Report) in a research note released on Thursday,Benzinga reports. They currently have a $85.00 price target on the electronics maker’s stock.

Several other equities research analysts have also issued reports on the stock. Barrington Research dropped their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Check Out Our Latest Stock Report on Dolby Laboratories

Dolby Laboratories Stock Performance

Shares of NYSE DLB opened at $62.03 on Thursday. The stock’s 50-day simple moving average is $65.40 and its 200-day simple moving average is $69.29. Dolby Laboratories has a fifty-two week low of $61.33 and a fifty-two week high of $89.66. The firm has a market capitalization of $5.92 billion, a PE ratio of 23.59 and a beta of 0.88.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. During the same period last year, the business posted $0.61 EPS. The company’s quarterly revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, sell-side analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.

Insiders Place Their Bets

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the sale, the executive vice president directly owned 73,054 shares in the company, valued at $4,874,893.42. The trade was a 11.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the completion of the transaction, the senior vice president directly owned 67,435 shares in the company, valued at approximately $4,420,364.25. The trade was a 4.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 137,120 shares of company stock worth $9,184,809. 37.93% of the stock is owned by insiders.

Institutional Trading of Dolby Laboratories

Institutional investors have recently added to or reduced their stakes in the stock. First Horizon Corp bought a new stake in shares of Dolby Laboratories in the 3rd quarter worth about $25,000. Hantz Financial Services Inc. grew its stake in Dolby Laboratories by 166.7% in the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares in the last quarter. Allworth Financial LP grew its stake in Dolby Laboratories by 590.4% in the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Mather Group LLC. bought a new stake in Dolby Laboratories in the third quarter valued at about $38,000. Finally, Rothschild Investment LLC lifted its holdings in Dolby Laboratories by 4,046.7% during the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after buying an additional 607 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Stories

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.